COMP <GO>
HQL vs FTHY // RSI-14 & 200D SMA MOMENTUM
abrdn Life Sciences Investors (NYSE) VS. First Trust High Yield Opportunities 2027 Term Fund (NYSE) • 15-METRIC TALLY: HQL 0
— FTHY 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: FTHY
LAST: $18.74 (+2.52%) • MKT CAP: $481.2M
rsi-technicals
53.0
LAST: $13.10 (+0.54%) • MKT CAP: $481.7M
rsi-technicals
57.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HQL VS. FTHY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HQL | FTHY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 53.0 | 57.0 | -4.03 | FTHY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $481.2M | $481.7M | -$489.8K | FTHY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HQL REV | FTHY REV | HQL GROSS % | FTHY GROSS % | HQL FCF | FTHY FCF |
|---|---|---|---|---|---|---|
| INSPECT INDIVIDUAL XBRL MODELS AT HQL FA <GO> AND FTHY FA <GO>. | ||||||
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HQL // BETA —
FTHY // BETA —